It consists of a retrospective study with twenty-two individuals diagnosed with DRC: fourteen HD and eight CAPD, followed up in the dialysis center of Antonio Pedro University Hospital (HUAP) of Fluminense Federal University (UFF), between 2015 and 2017. Fifteen healthy control (HC) subjects were included, without diagnosed CKD. Patients with HIV positive, hepatitis A, B, and C, pregnant, cancer, smokers, alcoholics and those exposed to X-rays in the last 3 months, were excluded. Objectives: As oxidative stress and endothelial dysfunction may be linked to the higher prevalence of CVD in CKD patients, we measured the activities of the antioxidants enzymes: SOD and GPx and total NO levels in the plasma and serum of end-stage CKD patients undergoing dialysis therapy, comparing with the HC group. Methods: Quantification of NO levels was performed by fluorometric kit, while activities of SOD and GPx were determined using kinetic methods. Results: We found higher plasma SOD activity in HD (8.58 U/ml) and CAPD (10.14 U/ml), compared to C (3.73 U/ml) group, while GPx activity was decreased in HD (115.38 nmol/h/ml) and CAPD (122.76 nmol/h/ml) groups compared to HC group (275.83 nmol/h/ml). Total serum NO concentration was decreased in HD (14.09 pmol/μl) and CAPD (10.26 pmol/μl), compared to non-CKD patients (49.65 pmol/μl). Conclusion: Decreased total serum NO and GPx activities may lead to endothelial dysfunction and consequently a higher prevalence of CVD in CKD patients.
References
[1]
Chen, T.K., Knicely, D.H. and Grams, M.E. (2019) Chronic Kidney Disease Diagnosis and Management: A Review. JAMA, 322, 1294-1304. https://doi.org/10.1001/jama.2019.14745
[2]
Braun, M.M. and Khayat, M. (2021) Kidney Disease: End-Stage Renal Disease. FP Essentials, 509, 26-32.
[3]
Albakr, R.B. and Bargman, J.M. (2021) A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease. Cardiology Clinics, 39, 447-453. https://doi.org/10.1016/j.ccl.2021.04.013
[4]
Andrade-Oliveira, V., Foresto-Neto, O., Watanabe, I.K.M., Zatz, R. and Camara, N.O.S. (2019) Inflammation in Renal Diseases: New and Old Players. Frontiers in Pharmacology, 10, Article No. 1192. https://doi.org/10.3389/fphar.2019.01192
[5]
Daenen, K., Andries, A., Mekahli, D., et al. (2019) Oxidative Stress in Chronic Kidney Disease. Pediatric Nephrology, 34, 975-991. https://doi.org/10.1007/s00467-018-4005-4
[6]
Ebert, T., Pawelzik, S.C., Witasp, A., Arefin, S., Hobson, S., Kublickiene, K., et al. (2020) Inflammation and Premature Aging in Chronic Kidney Disease. Toxins (Basel), 12, Article No. 227. https://doi.org/10.3390/toxins12040227
[7]
Clermont, G., Lecour, S., Lahet, J., Siohan, P., Vergely, C., Chevet, D., et al. (2000) Alteration in Plasma Antioxidant Capacities in Chronic Renal Failure and Hemodialysis Patients: A Possible Explanation for the Increased Cardiovascular Risk in These Patients. Cardiovascular Research, 47, 618-623. https://doi.org/10.1016/S0008-6363(00)00117-6
[8]
Ruskowski, T., Jansen, E.H. and Antarorov, R. (2014) Evaluation of Assays for Measurement of Serum (Anti)Oxidants in Hemodialysis Patients. BioMed Research International, 2014, Article ID: 843157. https://doi.org/10.1155/2014/843157
[9]
Zargari, M. and Sedighi, O. (2015) Influence of Hemodialysis on Lipid Peroxidation, Enzymatic and Non-Enzymatic Antioxidant Capacity in Chronic Renal Failure Patients. Nephro-Urology Monthly, 7, e28526. https://doi.org/10.5812/numonthly.28526
[10]
Ogunleye, A., Akinbodewa, A.A., Adejumo, O.A., Oluwafemi, T.T. and Akinfaderin, D.A. (2018) Changes in Antioxidant Status Associated with Haemodialysis in Chronic Kidney Disease. Ghana Medical Journal, 52, 29-33. https://doi.org/10.4314/gmj.v52i1.6
[11]
Bogacka, A., Sobczak-Czynsz, A., Balejko, E., Heberlej, A. and Ciechanowski, K. (2022) Effect of Diet and Supplementation on Serum Vitamin C Concentration and Antioxidant Activity in Dialysis Patients. Nutrients, 15, Article No. 78. https://doi.org/10.3390/nu15010078
[12]
Ahmadmehrabi, S. and Tang, W.H.W. (2018) Hemodialysis-Induced Cardiovascular Disease. Seminars in Dialysis, 31, 258-267. https://doi.org/10.1111/sdi.12694
[13]
Meyer, C., Heiss, C., Drexhage, C., et al. (2010) Hemodialysis-Induced Release of Hemoglobin Limits Nitric Oxide Bioavailability and Impairs Vascular Function. Journal of the American College of Cardiology, 55, 454-459. https://doi.org/10.1016/j.jacc.2009.07.068
[14]
Liakopoulos, V., Roumeliotis, S., Gorny, X., Dounousi, E. and Mertens, P.R. (2017) Oxidative Stress in Hemodialysis Patients: A Review of the Literature. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 3081856. https://doi.org/10.1155/2017/3081856
[15]
Gutiérrez-Prieto, J.A., Soto-Vargas, J., Parra-Michel, R., Pazarín-Villasenor, H.L., García-Sánchez, A. and Miranda-Díaz, A.G. (2019) The Behavior of the Type of Peritoneal Transport in the Inflammatory and Oxidative Status in Adults under Peritoneal Dialysis. Frontiers in Medicine (Lausanne), 6, Article No. 210. https://doi.org/10.3389/fmed.2019.00210
[16]
Roumeliotis, S., Eleftheriadis, T. and Liakopoulos, V. (2019) Is Oxidative Stress an Issue in Peritoneal Dialysis? Seminars in Dialysis, 32, 463-466. https://doi.org/10.1111/sdi.12818
[17]
Capusa, C., Stoian, I., Rus, E., Lixandru, D., Barbulescu, C. and Mircescu, G. (2012) Does Dialysis Modality Influence the Oxidative Stress of Uremic Patients? Kidney and Blood Pressure Research, 35, 220-225. https://doi.org/10.1159/000331560
[18]
Reddy, Y.S., Kiranmayi, V.S., Sivakumar, V., et al. (2015) Nitric Oxide Status in Patients with Chronic Kidney Disease. Indian Journal of Nephrology, 25, 287-291. https://doi.org/10.4103/0971-4065.147376
[19]
Schmidt, R.J., Yokota, S., Tracy, T.S., Sorkin, M.I. and Baylis, C. (1999) Nitric Oxide Production Is Low in End-Stage Renal Disease Patients on Peritoneal Dialysis. American Journal of Physiology, 276, F794-F797. https://doi.org/10.1152/ajprenal.1999.276.5.F794
[20]
Hand, M.F., Haynes, W.G. and Webb, D.J. (1998) Hemodialysis and L-Arginin but Not D Arginin Correct Renal Faliure Associated Endothelial Dysfunction. Kidney International, 53, 1068-1077. https://doi.org/10.1111/j.1523-1755.1998.00851.x
[21]
Kovacevic, P., Dragic, S., Rajkovaca, Z., Veljkovic, S. and Kovacevic, T. (2014) Serum Levels of Nitric Oxide and Endothelin-1 in Patients Treated with Continuous Ambulatory Peritoneal Dialysis. Renal Failure, 36, 437-440. https://doi.org/10.3109/0886022X.2013.867812
[22]
Davenport, A., Fernando, R.L., Robson, R. and Varghese, Z. (2004) Nitric Oxide Production by Human Peritoneal Mesothelial Cells. The International Journal of Artificial Organs, 27, 15-23. https://doi.org/10.1177/039139880402700105
[23]
Noris, M., Benigni, A., Boccardo, P., et al. (1993) Enhanced Nitric Oxide Synthesis in Uremia: Implications for Platelet Dysfunction and Dialysis Hypotension. Kidney International, 44, 445-450. https://doi.org/10.1038/ki.1993.264
[24]
Zachara, B.A., Salak, A., Koterska, D., Manitius, J. and Wasowicz, W. (2004) Selenium and Glutathione Peroxidases in Blood of Patients with Different Stages of Chronic Renal Failure. Journal of Trace Elements in Medicine and Biology, 17, 291-299. https://doi.org/10.1016/S0946-672X(04)80031-2
[25]
Santangelo, F., Witko-Sarsat, V., Drüeke, T. and Descamps-Latscha, B. (2004) Restoring Glutathione as a Therapeutic Strategy in Chronic Kidney Disease. Nephrology Dialysis Transplantation, 19, 1951-1955. https://doi.org/10.1093/ndt/gfh266
[26]
González De Vega, R., Fernández-Sánchez, M.L., Fernández, J.C., álvarez, Menéndez, F.V. and Sanz-Medel, A. (2016) Selenium Levels and Glutathione Peroxidase Activity in the Plasma of Patients with Type II Diabetes Mellitus. Journal of Trace Elements in Medicine and Biology, 37, 44-49. https://doi.org/10.1016/j.jtemb.2016.06.007
[27]
Pazarín-Villasenor, L., García-Salas, Y., Yanowsky-Escatell, F.G., Pacheco-Moisés, F.P., Andrade-Sierra, J., Campos-Bayardo, T.I., Román-Rojas, D., García-Sánchez, A. and Miranda-Díaz, A.G. (2023) Oxidation State in Peritoneal Dialysis in Patients with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 24, Article No. 2669. https://doi.org/10.3390/ijms24032669
[28]
Theofilis, P., Vordoni, A., Koukoulaki, M., Vlachopanos, G. and Kalaitzidis, R.G. (2021) Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives. American Journal of Nephrology, 52, 693-701. https://doi.org/10.1159/000518456
[29]
Gonzáles-Rubianes, D.Z., Figueroa-Osorio, L.K., Benites-Zapata, V.A., Pacheco-Mendoza, J. and Herrera-Anazco, P. (2022) Utility of TG/HDL-C Ratio as a Predictor of Mortality and Cardiovascular Disease in Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Systematic Review. Hemodialysis International, 26, 137-146. https://doi.org/10.1111/hdi.12981
[30]
Sun, K., Lin, D., Li, F., Huang, C., Qi, Y., Xue, S., et al. (2015) Discordant Associations of Lipid Parameters with Albuminuria and Chronic Kidney Disease: A Population-Based Study. Lipids in Health and Disease, 14, Article No. 152. https://doi.org/10.1186/s12944-015-0153-8
[31]
Fujii, H., Kono, K. and Nishi, S. (2019) Characteristics of Coronary Artery Disease in Chronic Kidney Disease. Clinical and Experimental Nephrology, 23, 725-732. https://doi.org/10.1007/s10157-019-01718-5
